Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
1985 | 1 |
2018 | 1 |
2019 | 1 |
2024 | 1 |
Search Results
4 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Hereditary factor X deficiency disease"
Page 1
Hereditary factor X deficiency in America survey: impact on quality of life and burden of disease in patients and caregivers.
Blood Coagul Fibrinolysis. 2024 Apr 1;35(3):73-81. doi: 10.1097/MBC.0000000000001275. Epub 2024 Feb 21.
Blood Coagul Fibrinolysis. 2024.
PMID: 38305129
Free PMC article.
Hereditary factor X deficiency (HFXD) is a rare bleeding disorder causing delayed haemostasis and potentially life-threatening bleeds. Patient/caregiver burden and diagnosis path have not been well characterized. THE AIM OF THIS STUDY WAS TO: describe …
Hereditary factor X deficiency (HFXD) is a rare bleeding disorder causing delayed haemostasis and potentially li …
Acquired Factor X Deficiency in Patients With Primary Light Chain Amyloidosis.
Dejhansathit S, Suvannasankha A.
Dejhansathit S, et al.
J Investig Med High Impact Case Rep. 2019 Jan-Dec;7:2324709619832332. doi: 10.1177/2324709619832332.
J Investig Med High Impact Case Rep. 2019.
PMID: 30947547
Free PMC article.
The prolonged prothrombin time, partial thromboplastin time, and low FX level, which are correctable by mixing study, are the disease hallmarks. An immediate goal of care is to stop bleeding. Clotting factor replacement requires close monitoring of coagulogram and FX level …
The prolonged prothrombin time, partial thromboplastin time, and low FX level, which are correctable by mixing study, are the disease …
Item in Clipboard
Efficacy, safety and pharmacokinetics of a new high-purity factor X concentrate in women and girls with hereditary factor X deficiency.
Kulkarni R, James AH, Norton M, Shapiro A.
Kulkarni R, et al.
J Thromb Haemost. 2018 May;16(5):849-857. doi: 10.1111/jth.13983. Epub 2018 Apr 10.
J Thromb Haemost. 2018.
PMID: 29460388
Free article.
Clinical Trial.
Essentials Plasma-derived factor X concentrate (pdFX) is used to treat hereditary factor X deficiency. pdFX pharmacokinetics, safety and efficacy were assessed in factor X-deficient women/girls. ...On-demand pdFX 25 IU kg(-1) was effective and safe in …
Essentials Plasma-derived factor X concentrate (pdFX) is used to treat hereditary factor X deficiency. pdFX phar …
Item in Clipboard
Heterogeneity of hereditary and acquired factor X deficiencies by combined immunochemical and functional analyses.
Fair DS, Edgington TS.
Fair DS, et al.
Br J Haematol. 1985 Feb;59(2):235-48. doi: 10.1111/j.1365-2141.1985.tb02990.x.
Br J Haematol. 1985.
PMID: 3970856
These included those of hereditary type, transiently acquired deficiency as well as factor X deficiency associated with amyloidosis. ...The results suggest that a broad spectrum of molecular aberrations exist in the factor X deficiency …
These included those of hereditary type, transiently acquired deficiency as well as factor X deficiency associat …
Item in Clipboard
Cite
Cite